RPL5P15

Across TCGA pan-cancer cohorts, RPL5P15 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RPL5P15 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPL5P15 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL5P15 expression acts as an unfavorable survival marker, although some lineages such as ESCA and THCA show a favorable association.

STAD, ESCA, and THCA are the cancer types where RPL5P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	IV	0.131	0.679	<.001	57	view →
ESCA	OS	Tertile	IV	0.922	0.247	.024	21	view →
THCA	DFS	Tertile	All	0.933	0.799	.022	21	view →
LUAD	OS	Tertile	III,IV	0.240	0.540	.026	18	view →
PAAD	OS	Tertile	All	0.362	0.606	.032	9	view →
UVM	OS	Tertile	III,IV	0.439	0.727	.016	9	view →
HNSC	DFS	Tertile	III,IV	0.465	0.257	.046	6	view →
READ	DFS	Tertile	II,III,IV	0.829	0.397	.039	6	view →
SKCM	OS	Tertile	III,IV	1.000	0.806	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RPL5P15–STAD (DFS)

Open the STAD breakdown →